Culture

Political partisanship has had outsized influence on individual social mobility during COVID-19 pand

In the United States, political partisanship has played a much stronger role in individuals' decisions to limit their social mobility during the COVID-19 pandemic than the local incidence of the disease in their own communities, according to a new survey-based study of 1,135,638 million responses collected between April 4 and September 10, 2020 via Survey Monkey from randomly chosen people. The analysis, based on an average of 6,744 responses daily during the study period, suggests partisanship has been roughly 27 times more important than local COVID-19 prevalence for explaining individual mobility. In addition, Joshua Clinton and colleagues also found that self-identified Democrats were 13.1% less likely to be socially mobile compared with independents, while Republicans were 27.8% more likely to be mobile. Notably, this gulf widened over time, driven largely by increasing unwillingness on the part of self-identified Republicans to limit their mobility. The researchers weighted each day's sample cohort to be representative of the country's adult population using current estimates from the U.S. Census Bureau's American Community Survey. Each survey asked respondents to identify their political affiliation (Democrat, Republican, or Independent) and to report whether, in the preceding 24 hours, they had engaged in activities such as going to a restaurant, visiting family or friends, taking a walk, exercising, getting groceries, receiving medical care, or going to work. While the analysis primarily focused on the daily aggregate of all such activities, the researchers also found similar trends among individual activities as well, and further noted that the gap was even more pronounced when looking at riskier, voluntary activities such as eating at a restaurant or visiting with family or friends. "These differences have tremendous consequences for the ability of the United States to limit the spread of COVID-19," the authors write, further noting that their results "add to a growing consensus that partisanship is a key factor in explaining behavior and attitudes surrounding the COVID-19 pandemic."

Credit: 
American Association for the Advancement of Science (AAAS)

New insights about age-related macular degeneration could spur better treatments

BOSTON - "Wet" age-related macular degeneration (AMD) is one of the most common causes of irreversible vision loss in the elderly, and it occurs when abnormal and leaky blood vessels form in the retina, in part due to inflammation. New research by investigators at Massachusetts General Hospital (MGH) reveals insights into potential drivers of the disease -- which currently has no cure -- that could be targeted through prevention or treatment strategies. The findings are published in eLife.

Two inflammatory pathways involving complement (which is an immune system component) and a protein complex called the inflammasome (which, as its name suggests, triggers inflammation) promote the formation of abnormal blood vessels that are hallmarks of wet AMD, but it's unclear how these pathways are activated. Previous studies suggest that the inflammasome may be activated by a protein called NLRP3, mainly in the retinal pigment epithelium of the eye (a cell layer that separates the vascular layer of the eye from the retina).

To investigate further, researchers conducted experiments in a mouse model of wet AMD. The team showed that inflammasome activation by NLRP3 occurs mainly in cells called macrophages and microglia, but not in the retinal pigment epithelium. The scientists also discovered that proteins other than NLRP3 can lead to inflammasome activation and worsening of wet AMD.

"This means that rather than targeting only NLRP3 in wet AMD, it may be beneficial to block essential proteins of the inflammasome instead that are required for its activation, independently of whether NLRP3 or other proteins initiate inflammasome activation," explains senior author Alexander G. Marneros, MD, PhD, a principal investigator at MGH's Cutaneous Biology Research Center and an associate professor of Dermatology at Harvard Medical School. "Our findings provide guidance on how to block inflammasomes in wet AMD."

Marneros notes that previous studies conducted in cells suggest that complement activation can in turn lead to inflammasome activation, but this study in mice found that this activation occurs largely independently from complement-mediated inflammation. "Our study in a mouse model defines the cell types that contribute to inflammasome-mediated inflammation in wet AMD and uncovers the specific roles and contributions of NLRP3 inflammasomes, non-NLRP3-inflammasomes, and complement for the manifestation of wet AMD," he says.

In addition to providing new insights into how inflammation is regulated in wet AMD, the study also suggests that novel therapies that block inflammasome-mediated inflammation could be improved when combined with treatments that inhibit complement-mediated inflammation. "A combined therapeutic approach that blocks both these inflammatory pathways is likely going to have synergistic effects in lessening the symptoms of wet AMD. Thus, our findings in this mouse model may have important clinical relevance for novel therapies for this common blinding disease," says Marneros.

Credit: 
Massachusetts General Hospital

Access to nature important for mental health during Covid lockdowns

People in European countries with the strictest COVID-19 lockdown policies were more likely to show symptoms of depression and anxiety, according to an international study investigating the impact of disconnecting from nature.

Led by the Basque technology center AZTI, and involving the University of Exeter, the study built on pre COVID-19 evidence that access to outdoor spaces benefitted mental health and wellbeing. Researchers sought to answer the question of whether being forced to disconnect from nature affected mental health. The study, published in the journal Science of the Total Environment, was carried out during the first wave of COVID-19 in Europe (March-May 2020).

The team of international researchers from Spain, United Kingdom and Norway invited citizens to voluntarily respond a simple questionnaire to check their behaviour and mental health status in the face of severe measures that restricted mobility. In less than 20 days, 6,769 people from 77 different countries answered the survey, although for analysis purposes we focused on 5,218 responses from 9 countries.

Dr Sarai Pouso, from AZTI, who led the research, said: "The main conclusion is that people who were under the strictest lockdown during the first wave of COVID-19 (those who were only allowed to go out for work or essentials purchases, as was the case of Italy and Spain) were more likely to show symptoms compatible with depression and anxiety, compared to countries with more relaxed lockdowns where people could still visit natural places such as parks."

The researchers analyzed in greater detail the case of Spain, where, due to the epidemiological situation in March, the possibility for practicing outdoor activities, such as walking or playing sports, was totally forbidden. "The results indicate that having access from the home to outdoor spaces (e.g., garden, balcony) and having window views to open spaces or natural element (e.g., coast, park, forest) decreased the probability of showing symptoms of depression. Furthermore, people with access to outdoor spaces and with nature views, managed to maintain a more positive mood during lockdown", adds María C. Uyarra, who together with Dr Ángel Borja and Dr Sarai Pouso, made up the AZTI team involved in the study.

The effects of having access to gardens and views of nature from the home were far less important in countries in where people were allowed, or even encouraged, to visit parks and other natural locations as long as safe social distancing recommendations were adhered to (e.g. Norway, United Kingdom).

Results suggest that, under stressful circumstances such as lockdown, allowing people to spend some time outdoors in nature may help reduce the likelihood of developing symptoms of depression and or anxiety. This may be particularly important for people without gardens or views of nature, who are more likely to have lower incomes and live in more built up urban areas, concluded the research team.

Looking at different population subgroups, women and young people were more likely to experience symptoms of depression and anxiety. However, the researchers remain cautious. "The study was unable to obtain a fully representative sample and did not include data from certain groups that may have been particularly affected by the lockdown situation, such as children or many older adults" says Dr Mat White, from the University of Exeter, United Kingdom.

Results suggest that if governments have to implement new lockdown measures in the near future, they should consider allowing the population to spend some time outdoors. "Spending time outdoors has a protective effect on mental health. Restoring and expanding green and blue spaces in urban areas increases the resilience of cities in the face of pandemics", adds Erik Gómez-Baggethun, Professor at the Norwegian University of Life Sciences.

The study proposes that future urban developments should pay special attention to the inclusion of elements that would enable to contact with nature (e.g., more green areas in public spaces, etc.), as well as special attention to the most vulnerable sectors of the population.

"This research is important for so that future planners take into account that is crucial for people to have equal access to high-quality blue and green environments. We have now contributed to a robust and compelling body of evidence that tells us this access can both prevent and treat mental health issues, especially in urban areas. This is particularly key in the context of a pandemic, but actually it should be a planning priority that could improve our health, regardless of COVID-19" adds Lora E. Fleming, director of the European Centre for Environment and Human Health, from the University of Exeter.

"In summary, this study shows that the strict lockdown isolation to which certain populations (e.g., in Spain) were exposed had a negative effect on their mental health. However, we still do not know if these symptoms have been persistent or if they disappeared once the lockdown measures ended", concludes Dr Pouso.

Credit: 
University of Exeter

Artificial intelligence improves control of powerful plasma accelerators

image: The gas cell used as a plasma source. The laser arrives from the right of these images through the metal cone and enters the little cube, which is filled with gas. The laser ionises the gas and turns it into a plasma and creates the accelerator.

Image: 
Rob Shalloo

Researchers have used AI to control beams for the next generation of smaller, cheaper accelerators for research, medical and industrial applications.

Experiments led by Imperial College London researchers, using the Science and Technology Facilities Council's Central Laser Facility (CLF), showed that an algorithm was able to tune the complex parameters involved in controlling the next generation of plasma-based particle accelerators.

The algorithm was able to optimize the accelerator much more quickly than a human operator, and could even outperform experiments on similar laser systems.

These accelerators focus the energy of the world's most powerful lasers down to a spot the size of a skin cell, producing electrons and x-rays with equipment a fraction of the size of conventional accelerators.

The electrons and x-rays can be used for scientific research, such as probing the atomic structure of materials; in industrial applications, such as for producing consumer electronics and vulcanised rubber for car tyres; and could also be used in medical applications, such as cancer treatments and medical imaging.

Several facilities using these new accelerators are in various stages of planning and construction around the world, including the CLF's Extreme Photonics Applications Centre (EPAC) in the UK, and the new discovery could help them work at their best in the future. The results are published today in Nature Communications.

First author Dr Rob Shalloo, who completed the work at Imperial and is now at the accelerator centre DESY, said: "The techniques we have developed will be instrumental in getting the most out of a new generation of advanced plasma accelerator facilities under construction within the UK and worldwide.

"Plasma accelerator technology provides uniquely short bursts of electrons and x-rays, which are already finding uses in many areas of scientific study. With our developments, we hope to broaden accessibility to these compact accelerators, allowing scientists in other disciplines and those wishing to use these machines for applications, to benefit from the technology without being an expert in plasma accelerators."

The team worked with laser wakefield accelerators. These combine the world's most powerful lasers with a source of plasma (ionised gas) to create concentrated beams of electrons and x-rays. Traditional accelerators need hundreds of metres to kilometres to accelerate electrons, but wakefield accelerators can manage the same acceleration within the space of millimetres, drastically reducing the size and cost of the equipment.

However, because wakefield accelerators operate in the extreme conditions created when lasers are combined with plasma, they can be difficult to control and optimise to get the best performance. In wakefield acceleration, an ultrashort laser pulse is driven into plasma, creating a wave that is used to accelerate electrons. Both the laser and plasma have several parameters that can be tweaked to control the interaction, such as the shape and intensity of the laser pulse, or the density and length of the plasma.

While a human operator can tweak these parameters, it is difficult to know how to optimise so many parameters at once. Instead, the team turned to artificial intelligence, creating a machine learning algorithm to optimise the performance of the accelerator.

The algorithm set up to six parameters controlling the laser and plasma, fired the laser, analysed the data, and re-set the parameters, performing this loop many times in succession until the optimal parameter configuration was reached.

Lead researcher Dr Matthew Streeter, who completed the work at Imperial and is now at Queen's University Belfast, said: "Our work resulted in an autonomous plasma accelerator, the first of its kind. As well as allowing us to efficiently optimise the accelerator, it also simplifies their operation and allows us to spend more of our efforts on exploring the fundamental physics behind these extreme machines."

The team demonstrated their technique using the Gemini laser system at the CLF, and have already begun to use it in further experiments to probe the atomic structure of materials in extreme conditions and in studying antimatter and quantum physics.

The data gathered during the optimisation process also provided new insight into the dynamics of the laser-plasma interaction inside the accelerator, potentially informing future designs to further improve accelerator performance.

Credit: 
Imperial College London

NBA 'bubble' reveals the ultimate home court advantage, study finds

Conventional wisdom has long recognized the power of home court advantage in basketball.

The specific reasons home teams perform better are less clear: Is it the adrenalin fueled by the roar of the crowd? Referees favoring the home team?

What about disruptions of the internal body clock from quickly crossing time zones and poor sleep for the traveling teams?

The body clock and sleep question especially intrigues Andrew McHill, Ph.D., an occupational health scientist at Oregon Health & Science University who specializes in sleep disturbance and circadian rhythms.

In a study published in the journal Scientific Reports, McHill and his colleague closely examined the travel performance of elite professional basketball players. Their conclusion: Whether you're LeBron James or a rec-league scrub who travels for business, your performance on the road depends to a large degree on the alignment of your internal body clock with the new time zone and the quality of your sleep.

"Travel is hard for everyone," McHill said. "If you're a businessman who needs to present a sales pitch, being accurate and precise could be very important. This study suggests that small misalignments between the internal body clock and a new time zone (i.e., jet lag) can impact your accuracy and impair performance. To best adapt, you'll want to get acclimated to your new time zone as quickly as possible."

The weirdly truncated pro basketball season of 2019-20 afforded a prime opportunity for a natural experiment.

After halting its season in March due to the COVID-19 pandemic, the National Basketball Association resumed the last two months of the season in July with the 22 top teams confined to play in a travel-less "bubble" within Walt Disney World in Orlando, Florida.

"I'm a big sports fan, and I always wanted to look at how travel - and potentially jet lag and sleep disturbance - impacts sports performance," he said. "When the NBA suspended its season, and then started this bubble experiment in Orlando, I realized it was an opportunity to do what I'd been thinking about for a long time."

McHill partnered with a grad school colleague, Evan Chinoy, a sleep and circadian physiologist who works in San Diego for Leidos Inc., a biomedical research firm.

The researchers used this unique opportunity to compare the performance of teams during travel before the COVID-19 pandemic with the performance of those same teams comfortably ensconced at Disney World.

In their analysis, McHill and Chinoy were able to discern statistically significant differences in performance among teams that traveled within their time zone and across time zones. Specifically, researchers found teams that didn't travel had improved shooting accuracy and rebounding, although McHill said the detriments may be attributed to different factors.

"Shooting was affected by travel across time zones, whereas rebounding was impacted by travel in general," McHill said.

When a team travels across the country into different time zones, the mismatch between the new time zone and the team's home time zone has a physiological effect in a very specific part of the body: the suprachiasmatic nucleus of the brain's hypothalamus. In a precise activity like shooting a basketball, even slightly disrupting a player's central circadian clock could be the difference between a ball that swishes through the net and one that rattles in and out of the rim.

The study found that shooting accuracy in the bubble improved significantly.

"Everyone was shooting better," McHill said. "There was a lot more scoring. In any given game, you didn't have one team that was shooting worse like you normally would."

Rebounding, by contrast, is an activity that tends to reflect brute-force effort.

The study found that visiting teams didn't rebound as well, whether the game was played within its own time zone or three time zones away. This is likely due to the fact that a player is apt to get a good night's sleep at home compared to sleeping in a hotel.

Notably, the overall decline in performance appeared to be disproportionately experienced by East Coast teams traveling west.

"Most NBA games start at 7 or 8 p.m., so when the New York Knicks play in Portland, they are really starting the game at 11 p.m. on their body clock," he said. "By the time it's crunch time late in the fourth quarter, it may be 2 a.m. on their clock while it's 11 p.m. for the Blazers."

By contrast, the Blazers typically tip off at 4 p.m. Portland time during their East Coast road trips.

This would seem to be an advantage for Western Conference teams, which have won 15 of the 22 NBA championship series played since Michael Jordan and the Chicago Bulls dynasty of the 1990s. McHill, a longtime Blazers fan with searing childhood memories of the team falling just short of the NBA Finals in 2000, discounts this.

"It gets confounded by the fact that the Western Conference has had so many great players over the years," he said. "I'm also a baseball fan. Think about how the Mariners have struggled over the years, and that argument somewhat goes out the window."

Either way, McHill said his findings suggest that NBA teams may be better off boarding a plane for the next city immediately after their previous game ends - as opposed to staying overnight and then flying the next day.

"To best adapt to a new time zone, you'll want to arrive at your 'away' destination as soon as possible," he said. "This study may suggest it's worth getting acclimated to your new time zone as quickly as possible. It may mean flying after the game, even though it's late.

"This type of schedule would have to be evaluated on a game-by-game basis, as you also don't want to impact sleep too greatly. It's a fine balance that still needs to be worked out."

Credit: 
Oregon Health & Science University

Scientists build whole functioning thymus from human cells

Researchers at the Francis Crick Institute and University College London have rebuilt a human thymus, an essential organ in the immune system, using human stem cells and a bioengineered scaffold. Their work is an important step towards being able to build artificial thymi which could be used as transplants.

The thymus is an organ in the chest where T lymphocytes, which play a vital role in the immune system, mature. If the thymus does not work properly or does not form during foetal development in the womb, this can lead to diseases such as severe immunodeficiency, where the body cannot fight infectious diseases or cancerous cells, or autoimmunity, where the immune system mistakenly attacks the patient's own healthy tissue.

In their proof-of-concept study, published in Nature Communications today [Friday 11th December], the scientists rebuilt thymi using stem cells taken from patients who had to have the organ removed during surgery. When transplanted into mice, the bioengineered thymi were able to support the development of mature and functional human T lymphocytes.

While researchers have previously rebuilt other organs or sections of organs, this is the first-time scientists have successfully rebuilt a whole working human thymus. The study, which was mainly funded by the European Research Council (ERC),* is an important step not only for further research into and treatment of severe immune deficiencies but also more broadly for developing new techniques to grow artificial organs.

Sara Campinoti, author and researcher in the Epithelial Stem Cell Biology and Regenerative Medicine Laboratory at the Crick says: "Showing it is possible to build a working thymus from human cells is a crucial step towards being able to grow thymi which could one day be used as transplants".

To rebuild this organ, the researchers collected thymi from patients and in the laboratory, grew thymic epithelial cells and thymic interstitial cells from the donated tissue into many colonies of billions of cells.

The next step for the researchers was to obtain a structural scaffold of thymi, which they could repopulate with the thymic cells they had cultured. For this, researcher Asllan Gjinovci developed a new approach to remove all the cells from rat thymi, so only the structural scaffolds remained. They had to use a new microvascular surgical approach for this, as conventional methods are not effective for the thymus.

Asllan says: "This new approach is important because it enables us to obtain scaffolds from larger organs like the human thymus, something essential to bringing this beautiful work to the clinic."

The researchers then injected the organ scaffolds with up to six million human thymic epithelial cells as well as interstitial cells from the colonies they had grown in the lab. The cells grew onto the scaffolds and after only five days, the organs had developed to a similar stage as those seen in nine-week old foetuses.

Finally, the team implanted these thymi into mice. They found that in over 75% of cases, the thymi were able to support the development of human lymphocytes.

Roberta Ragazzini, another author of the paper, adds: "The fact that we can extensively expand thymic stem cells taken from human donors into large colonies is really exciting. It makes it possible to scale up the process with a view to build 'human size' thymi."

Paola Bonfanti, senior author and group leader at the Crick and professor in the Division of Infection and Immunity at UCL says: "As well as providing a new source of transplants for people without a working thymus, our work has other potential future applications.

"For example, as the thymus helps the immune system to recognise self from non-self, it poses a problem for organ transplants as it can cause the immune system to attack the transplant.

"It is possible that we could overcome this by also transplanting a thymus regrown from cells taken from the thymus of the organ donor. We are confident that this may prevent the body attacking the transplant. The research behind this is still in early days, but it is an exciting concept which could remove the need for patients to take immune suppressors for the rest of their life.

The researchers are continuing their work rebuilding thymi to refine and scale up the process.

Credit: 
The Francis Crick Institute

Flavors added to vaping devices can damage the heart

video: Magnified images of beating heart muscle cells derived from human pluripotent stem cells.

Image: 
Video courtesy of Thomas McDonald, USF Health

TAMPA, Fla (Dec. 11, 2020) -- The appealing array of fruit and candy flavors that entice millions of young people take up vaping can harm their hearts, a preclinical study by University of South Florida Health (USF Health) researchers found.

Mounting studies indicate that the nicotine and other chemicals delivered by vaping, while generally less toxic than conventional cigarettes, can damage the lungs and heart. "But so far there has been no clear understanding about what happens when the vaporized flavoring molecules in flavored vaping products, after being inhaled, enter the bloodstream and reach the heart," said the study's principal investigator Sami Noujaim, PhD, an associate professor of molecular pharmacology and physiology at the USF Health Morsani College of Medicine.

In their study published Nov. 20 in the American Journal of Physiology- Heart and Circulatory Physiology, Dr. Noujaim and colleagues report on a series of experiments assessing the toxicity of vape flavorings in cardiac cells and in young mice.

"The flavored electronic nicotine delivery systems widely popular among teens and young adults are not harm-free," Dr. Noujaim said. "Altogether, our findings in the cells and mice indicate that vaping does interfere with the normal functioning of the heart and can potentially lead to cardiac rhythm disturbances."

Dr. Noujaim's laboratory is among the first beginning to investigate the potential cardiotoxic effects of the many flavoring chemicals added to the e-liquids in electronic nicotine delivery systems, or ENDS. He recently received a five-year, $2.2-million grant from the NIH's National Institute of Environmental Health Sciences to carry out this laboratory research. Commonly called e-cigarettes, ENDS include different products such as vape pens, mods, and pods.

Vaping involves inhaling an aerosol created by heating an e-liquid containing nicotine, solvents such as propylene glycol and vegetable glycerin, and flavorings. The vaping device's battery-powered heat converts this e-liquid into a smoke-like aerosolized mixture (e-vapor). Manufacturers tout e-cigarettes as a tool to help quit smoking, but evidence of their effectiveness for smoking cessation is limited, and they are not FDA approved for this use. E-cigarettes contain the same highly addictive nicotine found in tobacco products, yet many teens and young adults assume they are safe.

Among the USF Health study key findings:

- In mouse cardiac muscle cells (HL-1 cells), the researchers tested the toxicity of three different, popular flavors of e-liquid: fruit flavor, cinnamon, and vanilla custard. All three were toxic to HL-1 cells exposed to e-vapor bubbled into the laboratory dish where the cells were cultured.

- Cardiac cells derived from human pluripotent stem cells were exposed to three distinct e-vapors. The first e-vapor containing only solvent interfered with the electrical activity and beating rate of cardiac cells in the dish. A second e-vapor with nicotine added to the solvent increased the toxic effects on these cells. The third e-vapor comprised of nicotine, solvent, and vanilla custard flavoring (the flavor previously identified as most toxic) augmented damage to the spontaneously beating cells even more. "This experiment told us that the flavoring chemicals added to vaping devices can increase harm beyond what the nicotine alone can do," Dr. Noujaim said.

- Healthy young mice implanted with tiny electrocardiogram devices were exposed to 60 puffs of vanilla-flavored e-vapor five days a week, for 10 weeks. Heart rate variability (HRV) - that is, fluctuations in the time interval between successive heartbeats - decreased in these test mice compared to the control mice that inhaled only puffs of air under the same regimen. A sophisticated analysis by the USF Health researchers showed that vaping interfered with normal HRV in the mice by disrupting the autonomic nervous system's control of heart rate (the acceleration and slowing down of heartbeats), Dr. Noujaim said.

- Finally, mice exposed to vaping were more prone to an abnormal and dangerous heart rhythm disturbance known as ventricular tachycardia compared to control mice.

Whether the mouse findings will translate to people is unknown. Dr. Noujaim emphasizes that more preclinical and human studies are needed to further determine the safety profile of flavored ENDS and their long-term health effects.

A partial government ban on flavored e-cigarettes aimed at stopping young people from vaping focused on enforcement against flavored e-cigarettes with pre-filled cartridges, like those produced by industry leader JUUL. However, teens quickly switched to newer disposable e-cigarettes still sold in a staggering assortment of youth-appealing fruity and dessert-like flavors.

"Our research matters because regulation of the vaping industry is a work in progress," Dr. Noujaim said. "The FDA needs input from the scientific community about all the possible risks of vaping in order to effectively regulate electronic nicotine delivery systems and protect the public's health. At USF Health, in particular, we will continue to examine how vaping may adversely affect cardiac health."

Credit: 
University of South Florida (USF Health)

New report finds global health research infrastructure imperiled by COVID-19

The strong foundation of global health research and development (R&D) that greatly accelerated the development of COVID-19 innovations is now being weakened by pandemic pressures that are diverting funding and expertise away from other dangerous diseases and putting clinical trials and scientific endeavors around the world on indefinite hold.

That's a key conclusion of a new report released today from the non-profit Global Health Technologies Coalition (GHTC). It's based on qualitative interviews with experts in academia, philanthropy, industry, government agencies and product development partnerships discussing how the battle against one all-consuming global health threat--COVID-19--is affecting efforts to combat a wide range of other diseases still sickening and killing millions of people worldwide.

"A lot of veterans of global health R&D are confronting a confounding situation of a pandemic that has generated new appreciation for the value of their work while at the same time potentially causing long-term harm to the field," said GHTC Director Jamie Bay Nishi. "Global health R&D has always subsisted on thin budgets and a tight-knit coalition of infectious disease experts--and both of these, funding and talent, are being redirected to COVID-19, which is putting many important projects in a precarious position."

The interviews, conducted anonymously, included experts working at the forefront of developing new innovations for fighting challenging problems like HIV/AIDS, tuberculosis, malaria, dengue and a host of neglected tropical diseases. They discussed how research and product development efforts for poverty-related and neglected diseases, already fighting for resources before COVID-19 hit, are now "at significant risk of disruption due to the pandemic, despite the sector's central role in enabling the COVID-19 R&D response."

One immediate impact is that global health expertise has been in high demand, forcing many researchers to put all other projects aside. The report notes that two people at key U.S. government agencies said that "half their teams have been deployed to COVID-19 response." A representative of a private sector company noted staffing shortages as personnel were diverted to developing COVID-19-related products. There were reports of labs affiliated with academic research institutions, normally focused on various neglected diseases, shifting their staff and facilities to deal with state or university COVID-19 testing demands. In one case, a lab's entire discretionary budget was spent responding to state testing demands, so far without compensation.

Clinical trials--the most costly and complex aspect of developing new health interventions--have been hit especially hard. Nearly every interviewee involved in clinical trials, many of which are located in low- and middle-income countries, reported significant issues, including many being delayed indefinitely. The biggest problems involved the most consequential trials: phase 3 trials that, if successful, are the last hurdle in the long march to product licensure. But they are also the largest and most logistically challenging as they typically involve thousands of participants.

Researchers reported pausing many or all of their late-stage trials. One clinical trial administrator reported that where a trial was already underway, numerous trial participants were not showing up for essential follow-up visits at the clinic because of fear of contracting COVID-19. People managing clinical trials said switching to virtual visits was proving challenging, in part due to infrastructure barriers in low-resource settings--such as the need for many people to regularly purchase new SIM cards for their phones, which changes their phone number--and because many trials require in-person follow-up to collect samples.

It was difficult to assess the impact to global health work at U.S. government agencies like the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the US Agency for International Development (USAID). But the interviews provided reason for concern.

For example, an official at one research center asked staff to estimate the funding they would need to accomplish COVID-19-related work while maintaining existing projects. The estimates were four times higher than the amount of supplemental funding provided by Congress to the center that was supposed to cover those costs. Another agency leader reported trying to hire contract workers to cover COVID-19 work so that existing staff could return to their research projects but acknowledged it can be difficult to backfill positions that require niche expertise.

Meanwhile, many respondents said their work has been stymied by the lack of reagents and personal protective equipment or PPE because both are urgently needed for pandemic-related duties. Even seemingly routine matters like shipping costs to send supplies to global research sites have become big concerns. One researcher working in a high-income country reported that the cost of international shipping had increased six-fold during the pandemic, which would have sapped the entire shipping budget for their five-year NIH grant.

But there were also signs of hope that the pandemic could offer many benefits for the long-term effort to generate new innovations for fighting infectious diseases in low-income countries. One senior government scientist noted that the speed of COVID-19 vaccine development demonstrates to potential funders that, with adequate resources, there could be rapid progress is solving a wide array of global health challenges.

Other interviewees noted that the surge of COVID-19 alliances between governments and industry "has affirmed the value of public-private partnerships for producing new medical products." And there was excitement that new insights and technologies generated over the last few months, along with new approaches to conducting clinical trials, could have applications for many other diseases. The most optimistic opinion, while not universal, involved hopes that the pandemic could create "a new era in which global public health becomes an enduring political priority."

Ultimately, the report predicts global health research will emerge somewhere in the middle. It described the pandemic's impact on global health as operating like a "driverless bulldozer," alternately damaging certain areas while carving promising new paths in others.

"The critical role falls to policy makers to identify and restore vital global health initiatives that have been harmed by the pandemic while capitalizing on opportunities revealed by COVID-19 R&D to accelerate work on a number of diseases," Nishi said. "Their decisions will determine whether the legacy of COVID-19 is a tragic setback for the broader fight against infectious diseases or a new awareness of the incredible value of investing in global health innovations."

Credit: 
Burness

Record resolution in X-ray microscopy

Researchers at Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), the Paul Scherrer Institute in Switzerland and other institutions in Paris, Hamburg and Basel, have succeeded in setting a new record in X-ray microscopy. With improved diffractive lenses and more precise sample positioning, they were able to achieve spatial resolution in the single-digit nanometre scale. This new dimension in direct imaging could provide significant impulses for research into nanostructures and further advance the development of solar cells and new types of magnetic data storage. The findings have now been published in the renowned journal Optica with the title 'Soft X-ray microscopy with 7 nm resolution'.

Soft X-ray microscopy, which uses low-energy X-rays is used to investigate the properties of materials in the nanoscale. This technology can be used to determine the structure of organic films that play an important role in the development of solar cells and batteries. It also enables chemical processes or catalytic reactions of particles to be observed. The method allows the investigation of so-called spin dynamics. Electrons can not only transport electric charge, but also have an internal direction of rotation, which could be used for new types of magnetic data storage.

To improve research into these processes in the future, researchers need to be able to 'zoom' in to the single-digit nanometre scale. This is theoretically possible with soft X-rays, but up to now it has only been possible to achieve spatial resolution of below 10 nanometres using indirect imaging methods that require subsequent reconstruction. 'For dynamic processes such as chemical reactions or magnetic particle interaction, we need to be able to view the structures directly,' explains Prof. Dr. Rainer Fink from the Chair of Physical Chemistry II at FAU. 'X-ray microscopy is especially suitable for this as it can be used more flexibly in magnetic environments than electron microscopy, for example.'

Improved focusing and calibration

Working with the Paul Scherrer Institute and other institutions in Paris, Hamburg, and Basel, the researchers have now broken a new record in X-ray microscopy as they have succeeded in achieving a record resolution of 7 nanometres in several different experiments. This success is not based primarily on more powerful sources of X-rays, but on improving the focus of the rays using diffractive lenses and more precise calibration of the test samples. 'We optimised the structure size of the Fresnel zone plates which are used to focus X-rays,' explains Rainer Fink. 'In addition, we were able to position the samples in the device at a much higher accuracy and reproduce this accuracy.' It is precisely this limited positioning and the stability of the system as a whole that have prevented improvements in resolution in direct imaging up to now.

Remarkably, this record resolution was not only achieved with specially-designed test structures, but also in practical applications. For example, the researchers studied the magnetic field orientation of iron particles measuring 5 to 20 nanometres with their new optics. Prof. Fink explains: 'We assume that our results will push forward research into energy materials and nanomagnetism in particular. The relevant structure sizes in this fields are often below current resolution limits.'

Credit: 
Friedrich-Alexander-Universität Erlangen-Nürnberg

'The robot made me do it': Robots encourage risk-taking behaviour in people

image: A SoftBank Robotics Pepper robot was used in the two robot conditions. Pepper, 1.21-meter-tall with 25 degrees of freedom, is a medium-sized humanoid robot designed primarily for Human-Robot Interaction (HRI).

Image: 
University of Southampton

New research has shown robots can encourage people to take greater risks in a simulated gambling scenario than they would if there was nothing to influence their behaviours. Increasing our understanding of whether robots can affect risk-taking could have clear ethical, practiCal and policy implications, which this study set out to explore.

Dr Yaniv Hanoch, Associate Professor in Risk Management at the University of Southampton who led the study explained, "We know that peer pressure can lead to higher risk-taking behaviour. With the ever-increasing scale of interaction between humans and technology, both online and physically, it is crucial that we understand more about whether machines can have a similar impact."

This new research, published in the journal Cyberpsychology, Behavior, and Social Networking, involved 180 undergraduate students taking the Balloon Analogue Risk Task (BART), a computer assessment that asks participants to press the spacebar on a keyboard to inflate a balloon displayed on the screen. With each press of the spacebar, the balloon inflates slightly, and 1 penny is added to the player's "temporary money bank". The balloons can explode randomly, meaning the player loses any money they have won for that balloon and they have the option to "cash-in" before this happens and move on to the next balloon.

One-third of the participants took the test in a room on their own (the control group), one third took the test alongside a robot that only provided them with the instructions but was silent the rest of the time and the final, the experimental group, took the test with the robot providing instruction as well as speaking encouraging statements such as "why did you stop pumping?"

The results showed that the group who were encouraged by the robot took more risks, blowing up their balloons significantly more frequently than those in the other groups did. They also earned more money overall. There was no significant difference in the behaviours of the students accompanied by the silent robot and those with no robot.

Dr Hanoch said: "We saw participants in the control condition scale back their risk-taking behaviour following a balloon explosion, whereas those in the experimental condition continued to take as much risk as before. So, receiving direct encouragement from a risk-promoting robot seemed to override participants' direct experiences and instincts."

The researcher now believe that further studies are needed to see whether similar results would emerge from human interaction with other artificial intelligence (AI) systems, such as digital assistants or on-screen avatars.

Dr Hanoch concluded, "With the wide spread of AI technology and its interactions with humans, this is an area that needs urgent attention from the research community."

"On the one hand, our results might raise alarms about the prospect of robots causing harm by increasing risky behavior. On the other hand, our data points to the possibility of using robots and AI in preventive programs, such as anti-smoking campaigns in schools, and with hard to reach populations, such as addicts."

Credit: 
University of Southampton

The pressure sensor of the venus flytrap

image: Open trap of Dionaea muscipula with potential prey. Middle: basal part of a trigger hair, where action potentials are elicited in the sensory cells upon touch stimulation. During the late phase of the action potential, potassium ions need to be reimported into the sensory cells via KDM1 to enable the generation of consecutive action potentials.

Image: 
(Picture: Ines Kreuzer, Soenke Scherzer / University of Wuerzburg)

All plant cells can be made to react by touch or injury. The carnivorous Venus flytrap (Dionaea muscipula) has highly sensitive organs for this purpose: sensory hairs that register even the weakest mechanical stimuli, amplify them and convert them into electrical signals that then spread quickly through the plant tissue.

Researchers from Julius-Maximilians-Universität (JMU) Würzburg in Bavaria, Germany, have isolated individual sensory hairs and analysed the gene pool that is active in catching insects. "In the process, we found for the first time the genes that presumably serve throughout the plant kingdom to convert local mechanical stimuli into systemic signals," says JMU plant researcher Professor Rainer Hedrich.

That's a fine thing, because virtually nothing was known about mechano-receptors in plants until now. Hedrich's team presents the results in the open-access journal PLOS Biology.

Sensory hairs convert touch into electricity

The hinged trap of Dionaea consists of two halves, each carrying three sensory hairs. When a hair is bent by touch, an electrical signal, an action potential, is generated at its base. At the base of the hair are cells in which ion channels burst open due to a stretching of their envelope membrane and become electrically conductive. The upper part of the sensory hair acts as a lever that amplifies the stimulus triggered by even the lightest prey.

These micro-force-touch sensors thus transform the mechanical stimulus into an electrical signal that spreads from the hair over the entire flap trap. After two action potentials, the trap snaps shut. Based on the number of action potentials triggered by the prey animal during its attempts to free itself, the carnivorous plant estimates whether the prey is big enough - whether it is worth setting the elaborate digestion in motion.

From genes to the function of the touch sensor

To investigate the molecular basis for this unique function, Hedrich's team "harvested" about 1000 sensory hairs. Together with JMU bioinformatician Professor Jörg Schultz, they set out to identify the genes in the hairs.

"In the process, we noticed that the fingerprint of the genes active in the hair differs from that of the other cell types in the trap," says Schulz. How is the mechanical stimulus converted into electricity? "To answer this, we focused on the ion channels that are expressed in the sensory hair or are found exclusively there," says Hedrich.

In search of further ion channels

The sensory hair-specific potassium channel KDM1 stood out. Newly developed electrophysiological methods showed that without this channel, the electrical excitability of the sensory hairs is lost, i.e. they can no longer fire action potentials. "Now we need to identify and characterise the ion channels that play an important role in the early phases of the action potential," Hedrich said.

Credit: 
University of Würzburg

Majority of pregnant women who tested positive for COVID-19 were asymptomatic, study finds

The majority of pregnant women who tested positive for COVID-19 on arrival to the delivery room were asymptomatic, according to a paper by Mount Sinai researchers published in PLOS One on Thursday, December 10. The pregnant patients who tested positive for the coronavirus were also more likely than those who tested negative to identify as Hispanic and report their primary language as Spanish.

In a retrospective cross-sectional study of universal screenings for SARS-Cov-2, the virus that causes COVID-19, implemented in the labor and delivery unit of Elmhurst Hospital in Queens, New York, during March and April, the researchers found that more than one-third of almost 130 pregnant women tested positive for the coronavirus. This is a much higher proportion than reported at other hospitals in New York City during the pandemic surge, and likely related to social inequities experienced by the surrounding population. Elmhurst Hospital is a public hospital that serves a diverse, largely immigrant and low-income patient population that was severely affected by the COVID-19 pandemic in the spring. The majority, or 72 percent, of the pregnant patients who tested positive were asymptomatic, meaning they did not display any symptoms associated with COVID-19. These findings add to the evidence that there was early and rampant asymptomatic spread of the disease at a time when most community and hospital testing was limited to symptomatic individuals.

"This study is instructive for other labor and delivery units and hospitals across the world as we continue to refine pandemic preparedness," says Sheela Maru, MD, MPH, Assistant Professor of Global Health, and Obstetrics, Gynecology and Reproductive Science, at the Icahn School of Medicine at Mount Sinai. "In future epidemics, it may be prudent to look at labor and delivery screening numbers much earlier on, as pregnant women continue to seek essential care despite social distancing measures and also represent the general young and healthy community population."

Dr. Maru said universal screening in the labor and delivery unit ensured safety of patients and staff during an acute surge in COVID-19 infections through appropriate identification and isolation of pregnant women with positive test results. Women were roomed by their status and were provided postpartum counseling and follow-up protocols tailored to their specific social needs.

In addition to their status for COVID-19, the study reviewed patients' demographic data including age, ethnicity, primary language, zip code, marital status, and health insurance status, and clinical data including the mode of delivery, length of stay, and comorbidities such as chronic hypertension, preeclampsia, prepregnancy obesity, asthma, diabetes, depression, and anxiety.

Credit: 
The Mount Sinai Hospital / Mount Sinai School of Medicine

Masonic Medical Research Institute studies brown fat: Implications in obesity

image: The Lin Lab at the MMRI, quantified the number of brown fat cells present in newborn animals. For years, researchers have argued over whether brown fat continues to grow after birth. Dr. Lin and his team have become the first to prove that it does.

Image: 
Masonic Medical Research Institute

UTICA, NY -- Brown fat, also known as brown adipose tissue, is a special type of fat that "turns on" (becomes activated) when you get cold, to help maintain body temperature. Importantly, brown fat is a biological fuel that can increase the metabolic rate, decrease fat storage, and thereby, lower one's propensity for developing obesity. Interestingly, it was previously thought that individuals were born with only a finite number of brown fat cells. Here, and for the first time, a recent publication in the journal Scientific Reports identifies that brown fat can continue to grow and divide, even after birth. This finding has major implications; scientists can try to increase the overall number of these cells to prevent or reduce the onset of obesity.

Dr. Zhiqiang Lin, Assistant Professor and senior author of the manuscript, together with his research team at the Masonic Medical Research Institute (MMRI), quantified the number of brown fat cells present in newborn animals. "For years, researchers have been arguing over whether brown fat continues to grow after birth - we can now say with certainty that it does. This discovery opens a whole new direction for future breakthroughs. Our next step will focus on identifying the developmental signals responsible for the growth of brown fat cells and determining whether we can manipulate gene expression to generate more" said Dr. Lin.

The human body has two main forms of fat: brown and white. Brown fat acts as a furnace in the body, burning energy and turning it into heat. White fat, on the other hand, operates as a freezer, storing energy for later use. When the energy one consumes exceeds the energy exerted, obesity ensues. It is indeed a consequence of energy imbalance - white fat is storing more energy than brown fat is burning. This published manuscript is the first to suggest that brown fat cells continue to divide after birth, albeit only for a small window of 1-2 weeks. With this knowledge on hand, researchers can now interrogate the mechanisms that allow brown fat to grow and potentially devise ways to continue their propagation, as a means to control weight.

Credit: 
Masonic Medical Research Institute

Predicting British railway delays using artificial intelligence

image: Train schedule at a station near London.

Image: 
Debra Larson, The Grainger College of Engineering

Over the past 20 years, the number of passengers traveling on British train networks has almost doubled to 1.7 billion annually. With numbers like that it's clear how much people rely on rail service in Great Britain, and how many disgruntled patrons there would be when delays occur. A recent study used real British Railway data and an artificial intelligence model to improve the ability to predict delays in railway networks.

"We wanted to explore this problem using our experience with graph neural networks," said Huy Tran, an aerospace engineering faculty member at the University of Illinois Urbana-Champaign. "These are a specific class of artificial intelligence models that focus on data modeled as a graph, where a set of nodes are connected by edges."

"This was a collaboration with Simon Hu, an expert on railway networks, from the Zhejiang University-University of Illinois Urbana-Champaign Institute," Tran said. "We worked together to develop a new way to represent a rail network and apply it to real-world data to predict delays."

They applied the Spatial-Temporal Graph Convolutional Network model to predict delays within a portion of the British rail network where Didcot Parkway and Long Paddington serve as gateway stations.

"Compared with other statistical models, this one outperforms them for forecasting delays up to 60 minutes in the future," Tran said.

He added that others have developed similar models for social networks, but he wanted to apply it to an engineering problem.

"One challenge was that this data only captures the full trip of a train from start to finish. It doesn't tell us where it was delayed along the way," he said. "The new formulation we developed was a way to approximate in which leg of the trip the delay occurred. From this research, we learned that using our formulation with this class of AI models can work well with real-world networks to predict behaviors."

Tran said they are addressing some limitations, however.

"A lot of times with AI models, we don't really understand why the model says what it does. We just try to predict what the delay will be, but we don't have any insight into why it was delayed, or where," Tran said. "So, one of the things we're interested in is getting more explainability into these models, so we can better understand why it's making the suggestion or predictions that it does.

"We'd also like to at some point, close the loop and say, given this information, here's how you might want to react to that delay."

Credit: 
University of Illinois Grainger College of Engineering

Nutrigenomics: new frontiers

image: Addressing the latest advances at the intersection of postgenomics medicine, biotechnology and global society, including the integration of multi-omics knowledge, data analyses and modeling, and applications of high-throughput approaches to study complex biological and societal problems. Public policy, governance and societal aspects of the large-scale biology and 21st century data-enabled sciences

Image: 
Mary Ann Liebert, Inc., publishers

New Rochelle, NY, December 10, 2020--Plant omics and food engineering offer novel perspectives and value to sustainable agriculture and ecological sciences. They contribute to advances in nutrigenomics, according to a Special Issue on Plant Omics, Food Engineering and New Frontiers in Nutrigenomics in the peer-reviewed OMICS: A Journal of Integrative Biology. Click here (read the issue now.

"Nutrigenomics contributes to precision nutrition by unraveling the mechanisms of person-to-person and population differences in response to food exposures. Multi-omic variability in plants, and engineering of food composition, are the "input" functions leading to variability in nutritional outcomes. The OMICS December special issue presents new findings on plant omics and food engineering that address these knowledge dimensions. The articles signal new frontiers in nutrigenomics and the potentials of systems science-driven food engineering for precision nutrition," states Vural Özdemir, MD, PhD, Editor-in-Chief of OMICS: A Journal of Integrative Biology.

Plant omics is also relevant to identifying novel therapeutics for use in the current COVID-19 pandemic.

Featured in the special issue is an article by Anil Kumar, PhD, at Rani Lakhmi Bai Central Agricultural University, and coauthors. They discuss the future of food based on multi-omic analyses of iron and zinc homeostasis in finger millet, a staple food of agricultural importance worldwide.

Maria Taciana Cavalcanti Vieira Soares, at Rural Federal University of Pernambuco, Recife, and coauthors focused on the genetic mobility of Enterococcus faecium. They report on new findings and an approach based on comparison of the genetic mobility of (1) probiotic, (2) pathogenic, and (3) nonpathogenic and non-probiotic strains, so as to differentiate probiotics, and inform their safe use.

Credit: 
Mary Ann Liebert, Inc./Genetic Engineering News